Author Archives: Warren Woessner

ABBOTT LABS. v. SANDOZ, INC. – ONE RULE FITS ALL?

Or “what’s sauce for the goose is sauce for the gander”? Posts and pens have been busy reporting that the Federal Circuit, en banc, overruled Scripps v. Genentech, and ended the debate over whether a product-by-process claims should be construed … Continue reading →

Posted in Claim Interpretation | Tagged , , , , , , | Leave a comment

Congratulations

MERCEDES K. MYER, J.D., Ph.D., a partner at Drinker Biddle in DC was recently nominated (read “appointed”) to the Board of Directors of AIPLA. She was a the PTO Relations Subcommittee Chair when I was chair of the Biotechnology Committee … Continue reading →

Posted in People | Tagged , , | Leave a comment

GETTING TO ALLOWANCE – SEVEN HABITS OF HIGHLY EFFECTIVE CLIENTS

1. Tell Your Patent Attorney What You Want Your Patent To Do. IP attorneys are continuously told that we should be business partners with our clients, not just patent scribes. But there are lots of ways to protect an invention. … Continue reading →

Posted in USPTO Practice and Policy | Tagged , , , , , , , , | Leave a comment

BIO/CHEM/PHARMA CUSTOMER PARTNERSHIP CONTINUES – REPORT FROM 3/3/09 MEETING

Although this report (see link below) is of the March meeting, I hope to have current reports of meetings soon after they occur – if they continue to occur. It also gives me a chance to visit memory lane. In … Continue reading →

Posted in USPTO Practice and Policy | Tagged , , , , | Leave a comment